GLP-1 receptor agonist weight-loss drugs such as semaglutide may protect the cardiovascular system independent of weight loss.
“In Aliquot #128, I discuss how the new weight loss drugs like Ozempic® and Mounjaro® work, their pros and cons, and lifestyle strategies to optimize their effects for long-term health.”